Skip to main content
Home
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Type 2 diabetes and hyperglycemia

Journal articles and book chapters

05-05-2018 | Physical activity | Review | Article

May the force be with you: Why resistance training is essential for subjects with type 2 diabetes mellitus without complications

Codella R et al. Endocrine 2018; Advance online publication. doi: 10.1007/s12020-018-1603-7

04-05-2018 | Gestational diabetes | Article

The post-HAPO situation with gestational diabetes: The bright and dark sides

Lapolla A, Metzger BE. Acta Diabetol 2018; Advance online publication. doi: 10.1007/s00592-018-1146-7

03-05-2018 | Pregnancy | Review | Article

Pharmacotherapy for hyperglycemia in pregnancy: The new insulins

Toledano Y, Hadar E, Hod M. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.035

28-04-2018 | Heart failure | Review | Article

SGLT2 inhibition and heart failure: Current concepts

Custodio JS et al. Heart Fail Rev 2018; 23: 409–418. doi: 10.1007/s10741-018-9703-2

24-03-2018 | GLP-1 agonists | Review | Article

Use of glucagon‐like peptide‐1 receptor agonists among individuals on basal insulin requiring treatment intensification

Trautmann ME, Vora J. Diabet Med 2018; Advance online publication. doi: 10.1111/dme.13610

21-02-2018 | Medication adherence | Article

The influence of pharmacist-led adherence support on glycemic control in people with type 2 diabetes

Kharjul M, Braund R, Green J. Int J Clin Pharm 2018; Advance online publication. doi: 10.1007/s11096-018-0606-z

19-02-2018 | Nephropathy | Review | Article

The landscape of diabetic kidney disease in the United States

Duru OK et al. Curr Diab Rep 2018; 18: 14. doi: 10.1007/s11892-018-0980-x

05-02-2018 | Cardiovascular disorders | Review | Article

Clinical features and therapeutic perspectives on hypertension in diabetics

Katayama S, Hatano M, Issiki M. Hypertens Res 2018; 41: 213–229. doi: 10.1038/s41440-017-0001-5

11-01-2018 | Cardiovascular outcomes | Review | Article

Direct cardiovascular impact of SGLT2 inhibitors: Mechanisms and effects

Kaplan A et al. Heart Fail Rev 2018; 23: 419–437. doi: 10.1007/s10741-017-9665-9

30-06-2017 | Continuous glucose monitoring | Article

Assessing the therapeutic utility of professional continuous glucose monitoring in type 2 diabetes across various therapies: A retrospective evaluation

Kesavadev J et al. Adv Ther 2017; 34: 1918–1927. doi: 10.1007/s12325-017-0576-x

16-03-2017 | Glycemic control | Review | Article

Metrics for glycemic control: From HbA1c to continuous glucose monitoring

Nat Rev Endocrinol 2017; 13: 425–436. doi: 10.1038/nrendo.2017.3

10-11-2016 | Type 2 diabetes | Review | Article

Clinical pharmacokinetics and pharmacodynamics of antihyperglycemic medications in children and adolescents with type 2 diabetes mellitus

Akhlaghi F et al. Clin Pharmacokinet 2017; 56: 561–571. doi:10.1007/s40262-016-0472-6

11-08-2016 | Heart failure | Review | Article

Cardiometabolic syndrome and increased risk of heart failure

Von Bibra H, Paulus W, St John Sutton M. Curr Heart Fail Rep 2016; 13: 219–229. doi: 10.1007/s11897-016-0298-4

05-11-2015 | Insulin resistance | Review | Article

Insulin resistance: An additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes

Patel TP et al. Heart Fail Rev 2016; 21: 11–23. doi: 10.1007/s10741-015-9515-6

15-10-2015 | Hypoglycemia | Review | Article

Hypoglycemia and cardiovascular disease: Lessons from outcome studies

Pistrosch F, Hanefeld M. Curr Diab Rep 2015; 15: 117. doi: 10.1007/s11892-015-0678-2

07-08-2015 | Cardiovascular disorders | Article

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes

Paul SK et al. Cardiovasc Diabetol 2015; 14: 100. doi: 10.1186/s12933-015-0260-x

13-01-2015 | Heart failure | Article

Diastolic dysfunction in the diabetic continuum: Association with insulin resistance, metabolic syndrome and type 2 diabetes

Fontes-Carvalho R et al. Cardiovasc Diabetol 2015; 14: 4. doi: 10.1186/s12933-014-0168-x

01-12-2014 | SGLT2 inhibitors | Review | Article

Sodium glucose cotransporter-2 inhibitors: A review of their basic and clinical pharmacology

Kalra S. Diabetes Ther 2014; 5: 355–366. doi: 10.1007/s13300-014-0089-4

01-10-1993 | Hypertension | Article

Urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycemia and hypertriglyceridemia

Cull CA et al. Diabetologia 1993; 36: 1021–1029. doi: 10.1007/BF02374494

Previous
Image Credits